These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
492 related items for PubMed ID: 26751899
1. miRNAs as novel biomarkers in the management of prostate cancer. Filella X, Foj L. Clin Chem Lab Med; 2017 May 01; 55(5):715-736. PubMed ID: 26751899 [Abstract] [Full Text] [Related]
2. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue. Stephan C, Jung M, Rabenhorst S, Kilic E, Jung K. Clin Chem Lab Med; 2015 Jun 01; 53(7):1109-18. PubMed ID: 25720086 [Abstract] [Full Text] [Related]
3. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis. Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X. Prostate; 2017 May 01; 77(6):573-583. PubMed ID: 27990656 [Abstract] [Full Text] [Related]
4. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method. Xu Y, Qin S, An T, Tang Y, Huang Y, Zheng L. Prostate; 2017 Jul 01; 77(10):1167-1175. PubMed ID: 28617988 [Abstract] [Full Text] [Related]
5. Detection of miRNAs in urine of prostate cancer patients. Stuopelytė K, Daniūnaitė K, Jankevičius F, Jarmalaitė S. Medicina (Kaunas); 2016 Jul 01; 52(2):116-24. PubMed ID: 27170485 [Abstract] [Full Text] [Related]
12. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. Casanova-Salas I, Rubio-Briones J, Calatrava A, Mancarella C, Masiá E, Casanova J, Fernández-Serra A, Rubio L, Ramírez-Backhaus M, Armiñán A, Domínguez-Escrig J, Martínez F, García-Casado Z, Scotlandi K, Vicent MJ, López-Guerrero JA. J Urol; 2014 Jul 01; 192(1):252-9. PubMed ID: 24518785 [Abstract] [Full Text] [Related]
14. Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia. Stella M, Russo GI, Leonardi R, Carcò D, Gattuso G, Falzone L, Ferrara C, Caponnetto A, Battaglia R, Libra M, Barbagallo D, Di Pietro C, Pernagallo S, Barbagallo C, Ragusa M. Int J Mol Sci; 2024 Sep 19; 25(18):. PubMed ID: 39337566 [Abstract] [Full Text] [Related]
18. The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer. de Nóbrega M, Dos Reis MB, Pereira ÉR, de Souza MF, de Syllos Cólus IM. J Cancer Res Clin Oncol; 2022 Oct 19; 148(10):2893-2910. PubMed ID: 35922694 [Abstract] [Full Text] [Related]
19. Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research. Guelfi G, Cochetti G, Stefanetti V, Zampini D, Diverio S, Boni A, Mearini E. Sci Rep; 2018 May 08; 8(1):7111. PubMed ID: 29740090 [Abstract] [Full Text] [Related]
20. Urinary microRNAs expression in prostate cancer diagnosis: a systematic review. Paiva RM, Zauli DAG, Neto BS, Brum IS. Clin Transl Oncol; 2020 Nov 08; 22(11):2061-2073. PubMed ID: 32323148 [Abstract] [Full Text] [Related] Page: [Next] [New Search]